198 related articles for article (PubMed ID: 10404727)
21. Reliable analysis of phenylalanine and tyrosine in a minimal volume of blood.
Prinsen HC; Holwerda-Loof NE; de Sain-van der Velden MG; Visser G; Verhoeven-Duif NM
Clin Biochem; 2013 Sep; 46(13-14):1272-5. PubMed ID: 23726812
[TBL] [Abstract][Full Text] [Related]
22. [Differential diagnosis and therapy of various forms of hyperphenylalaninemia: facts and fiction].
Endres W
Wien Klin Wochenschr; 1992; 104(16):503-9. PubMed ID: 1413808
[TBL] [Abstract][Full Text] [Related]
23. DNA methylated alleles of the phenylalanine hydroxylase promoter remodeled at elevated phenylalanine levels in newborns with hyperphenylalaninemia.
Item CB; Farhadi S; Schanzer A; Greber-Platzer S
Clin Biochem; 2017 Aug; 50(12):729-732. PubMed ID: 28389235
[TBL] [Abstract][Full Text] [Related]
24. Newborn screening of phenylketonuria using direct analysis in real time (DART) mass spectrometry.
Wang C; Zhu H; Cai Z; Song F; Liu Z; Liu S
Anal Bioanal Chem; 2013 Apr; 405(10):3159-64. PubMed ID: 23397086
[TBL] [Abstract][Full Text] [Related]
25. Multivariate discrimination for phenylketonuria (PKU) and non-PKU hyperphenylalaninemia after analysis of newborns' dried blood-spot specimens for six amino acids by ion-exchange chromatography.
Reilly AA; Bellisario R; Pass KA
Clin Chem; 1998 Feb; 44(2):317-26. PubMed ID: 9474031
[TBL] [Abstract][Full Text] [Related]
26. A quantitative bacterial micro-assay for rapid detection of serum phenylalanine in dry blood-spots: application in phenylketonuria screening.
Vallian S; Moeini H
J Appl Genet; 2006; 47(1):79-83. PubMed ID: 16424613
[TBL] [Abstract][Full Text] [Related]
27. Hyperphenylalaninemia in a premature infant with heterozygosity for phenylketonuria.
Hennermann JB; Loui A; Weber A; Mönch E
J Perinat Med; 2004; 32(4):383-5. PubMed ID: 15346830
[TBL] [Abstract][Full Text] [Related]
28. Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control?
Daly A; Evans S; Chahal S; Santra S; MacDonald A
J Hum Nutr Diet; 2017 Aug; 30(4):515-523. PubMed ID: 28111827
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of neonatal BH4 loading test in neonates screened for hyperphenylalaninemia.
Feillet F; Chery C; Namour F; Kimmoun A; Favre E; Lorentz E; Battaglia-Hsu SF; Guéant JL
Early Hum Dev; 2008 Sep; 84(9):561-7. PubMed ID: 18321666
[TBL] [Abstract][Full Text] [Related]
30. Validation of amino-acids measurement in dried blood spot by FIA-MS/MS for PKU management.
Bruno C; Dufour-Rainfray D; Patin F; Vourc'h P; Guilloteau D; Maillot F; Labarthe F; Tardieu M; Andres CR; Emond P; Blasco H
Clin Biochem; 2016 Sep; 49(13-14):1047-50. PubMed ID: 27450222
[TBL] [Abstract][Full Text] [Related]
31. [Did the change of technique of screening investigations influence on improvement of test credibility in recognizing and differentiating diagnostics of hiperphenylalaninemias?].
Didycz B; Lemańska D; Słuszniak A
Przegl Lek; 2009; 66(1-2):11-3. PubMed ID: 19485249
[TBL] [Abstract][Full Text] [Related]
32. Phenylalanine and tyrosine measurements across gestation by tandem mass spectrometer on dried blood spot cards from normal pregnant women.
McBride KL; Pluciniczak J; Rhyand T; Bartholomew D
Genet Med; 2019 Aug; 21(8):1821-1826. PubMed ID: 30626901
[TBL] [Abstract][Full Text] [Related]
33. Use of the phenylalanine:tyrosine ratio to test newborns for phenylketonuria in a large public health screening programme.
Eastman JW; Sherwin JE; Wong R; Liao CL; Currier RJ; Lorey F; Cunningham G
J Med Screen; 2000; 7(3):131-5. PubMed ID: 11126161
[TBL] [Abstract][Full Text] [Related]
34. Optimization of Phenylalanine Cut-Off Value in Newborn Screening Based on Blood Sampling Time.
Liu Z; Jin H; Ye M; Han R; Han N; Zhao J
Am J Perinatol; 2024 May; 41(S 01):e995-e1000. PubMed ID: 36584692
[TBL] [Abstract][Full Text] [Related]
35. Cuban neonatal screening of phenylketonuria using an ultramicro-fluorometric test.
González EC; Frómeta A; del Río L; Castells E; Robaina MS; García SM; Licourt T; Arteaga AL; Martínez L
Clin Chim Acta; 2009 Apr; 402(1-2):129-32. PubMed ID: 19168043
[TBL] [Abstract][Full Text] [Related]
36. An automated enzymatic method on the Roche COBAS MIRA S for monitoring phenylalanine in dried blood spots of patients with phenylketonuria.
Randell EW; Lehotay DC
Clin Biochem; 1996 Apr; 29(2):133-8. PubMed ID: 8601321
[TBL] [Abstract][Full Text] [Related]
37. L-Phenylalanine concentration in blood of phenylketonuria patients: a modified enzyme colorimetric assay compared with amino acid analysis, tandem mass spectrometry, and HPLC methods.
De Silva V; Oldham CD; May SW
Clin Chem Lab Med; 2010 Sep; 48(9):1271-9. PubMed ID: 20604724
[TBL] [Abstract][Full Text] [Related]
38. Serum prolactin as a biomarker for the study of intracerebral dopamine effect in adult patients with phenylketonuria: a cross-sectional monocentric study.
Juhász E; Kiss E; Simonova E; Patócs A; Reismann P
Eur J Med Res; 2016 May; 21(1):22. PubMed ID: 27169416
[TBL] [Abstract][Full Text] [Related]
39. Phenylalanine tolerance tests. In families with phenylketonuria and hyperphenylalaninemia.
Cunningham GC; Day RW; Berman JL; Hsia DY
Am J Dis Child; 1969 Jun; 117(6):626-35. PubMed ID: 5771502
[No Abstract] [Full Text] [Related]
40. Discrimination of phenylketonurics from persistent hyperphenylalaninemia patients using a simple phenylalanine loading test.
Blitzer MG; Bailey-Wilson JE; Shapira E
Clin Chim Acta; 1985 Dec; 153(2):137-42. PubMed ID: 4064343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
